These findings suggest that ITGA11 may regulate the comorbidities of IAs and AAAs through mechanisms involving immune and inflammatory regulation, extracellular matrix interactions, and cell biological processes. This evidence concerns the gene ITGA11 and achalasia-alacrima syndrome.